Nanotechnologies are materials and devices that have a functional organization in at least
one dimension on the nanometer (one billionth of a meter) scale, ranging from a few to …

Neurodegenerative disorders including Alzheimer's and Parkinson's diseases, amyotrophic
lateral sclerosis, and stroke are rapidly increasing as population ages. The field of …

In spite of a great improvement in medical health services and an increase in lifespan, we
have witnessed a skyrocket increase in the incidence of central nervous system (CNS) …

Research into treatments for diseases of the CNS has made impressive strides in the past
few decades, but therapeutic options are limited for many patients with CNS disorders …

The incidence of neurological diseases of unknown etiology is increasing, including well-
studied diseases such as Alzhiemer's, Parkinson's, and multiple sclerosis. The blood-brain …

Abstract Treatment of brain‐related diseases is challenging due to the presence of the blood–
brain barrier (BBB), a hurdle that prevents most foreign matter from entering the brain. While …

Interest in nanoneuromedicine has grown rapidly due to the immediate need for improved
biomarkers and therapies for psychiatric, developmental, traumatic, inflammatory, infectious …

The major neurological disorders found in a central nervous system (CNS), such as brain
tumors, Alzheimer's diseases, Parkinson's diseases, and Huntington's disease, have led to …

Nanoscale structures have been at the core of research efforts dealing with integration of
nanotechnology into novel electronic devices for the last decade. Because the size of …

The design of a drug that successfully overcomes the constraints imposed by the blood–
brain barrier (BBB, which acts as a gatekeeper to the entry of substances into the brain) …